PATENT CLAIM ANALYSIS

Application Number: 15913792
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["514", "279000"]

Abstract:
An abuse deterrent opioid formulation for rectal use. The formulation contains a therapeutically effective amount of the opioid buprenorphine or salts and homologs thereof; and either a gel with a diminishing agent or a suppository base with a diminishing agent into which the opioid buprenorphine is mixed.

Claim (Index 6):
The abuse deterrent opioid formulation for rectal use of  claim 2 , wherein the gel has a viscosity in the range of 10,000 to 500,000 centipoise, and more preferably in the range of 25,000 to 250,000 centipoise, and even more preferably in the range of 40,000 to 80,000 centipose.

Metadata:
- Claim Count in Document: 56.0
- Percentile: 90.0
- Lexical Diversity: 1.42857
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12597702', '13926206', '12965572', '14339143', '12383906']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7954761655243034
- 35 USC 102 Novelty (BERT): 0.5224882956140875
- Combined Prediction Score: 0.7681773785332818
- Mean Citation Score: 258.38171600000004
- Max Citation Score: 277.38162
- Similarity Product: 155.07970780386685

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test